PURE Bioscience, Inc.
OTC:PURE
0.107 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1.963 | 1.877 | 1.853 | 3.927 | 6.917 | 1.909 | 1.774 | 1.831 | 1.289 | 0.729 | 0.55 | 0.82 | 0.812 | 0.464 | 1.436 | 0.728 | 1.487 | 0.336 | 0.2 | 0.156 | 0.263 | 2.589 | 3.206 | 2.41 | 1.661 | 3.4 | 1.7 | 1 | 0.8 |
Cost of Revenue
| 0.811 | 0.906 | 0.853 | 1.852 | 2.896 | 0.728 | 0.763 | 0.76 | 0.441 | 0.285 | 0.344 | 0.565 | 0.264 | 0.131 | 0.465 | 0.238 | 0.464 | 0.221 | 0.106 | 0.052 | 0.131 | 1.534 | 1.599 | 1.363 | 0.885 | 1.3 | 0.9 | 0.6 | 0.6 |
Gross Profit
| 1.152 | 0.971 | 1 | 2.075 | 4.021 | 1.181 | 1.011 | 1.071 | 0.848 | 0.444 | 0.206 | 0.255 | 0.548 | 0.333 | 0.971 | 0.49 | 1.024 | 0.115 | 0.095 | 0.104 | 0.133 | 1.056 | 1.608 | 1.047 | 0.776 | 2.1 | 0.8 | 0.4 | 0.2 |
Gross Profit Ratio
| 0.587 | 0.517 | 0.54 | 0.528 | 0.581 | 0.619 | 0.57 | 0.585 | 0.658 | 0.609 | 0.375 | 0.311 | 0.675 | 0.717 | 0.676 | 0.673 | 0.688 | 0.343 | 0.473 | 0.669 | 0.503 | 0.408 | 0.501 | 0.435 | 0.467 | 0.618 | 0.471 | 0.4 | 0.25 |
Reseach & Development Expenses
| 0.302 | 0.297 | 0.319 | 0.339 | 0.322 | 0.354 | 0.459 | 0.779 | 0.927 | 0.79 | 1.032 | 1.325 | 1.863 | 2.18 | 1.927 | 1.468 | 1.646 | 1.221 | 1.194 | 1.357 | 1.133 | 0.981 | 0.781 | 0.293 | 0.115 | 0.2 | 0.2 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 4.047 | 0 | 6.416 | 7.594 | 6.3 | 6.978 | 7.294 | 8.322 | 5.718 | 7.439 | 6.52 | 4.934 | 5.462 | 5.143 | 3.735 | 2.613 | 1.758 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.928 | 0.694 | 0.806 | 0.899 | 0.57 | 0.427 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 3.981 | 4.302 | 4.106 | 4.047 | 3.695 | 6.416 | 7.594 | 6.3 | 6.978 | 7.294 | 8.322 | 5.718 | 7.439 | 6.52 | 5.862 | 6.156 | 5.949 | 3.735 | 2.613 | 1.758 | 1.626 | 3.284 | 2.77 | 2.572 | 2.308 | 1.5 | 2.4 | 1.9 | 0.7 |
Other Expenses
| 0 | -0.004 | 0 | -0.004 | 0.005 | 0.001 | 0.025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.109 | 0 | 0 | 0 | 0 | 0 | 0.278 | 0 | 0.212 | 0.1 | 0.1 | 0.1 | 0 |
Operating Expenses
| 4.283 | 4.599 | 4.425 | 4.386 | 4.017 | 6.77 | 8.053 | 7.079 | 7.905 | 8.084 | 9.354 | 7.043 | 9.302 | 8.7 | 7.789 | 7.625 | 7.704 | 4.956 | 3.807 | 3.115 | 2.759 | 4.265 | 3.828 | 2.865 | 2.635 | 1.8 | 2.7 | 2 | 0.7 |
Operating Income
| -3.191 | -3.943 | -3.425 | -2.311 | 0.009 | -5.589 | -7.042 | -6.008 | 0.247 | -7.64 | -9.148 | -6.788 | -8.754 | -8.367 | -6.818 | -7.134 | -6.68 | -4.841 | -3.713 | -3.011 | -2.626 | -3.21 | -2.22 | -1.818 | -1.859 | 0.3 | -1.9 | -1.6 | -0.5 |
Operating Income Ratio
| -1.626 | -2.101 | -1.848 | -0.588 | 0.001 | -2.928 | -3.97 | -3.281 | 0.192 | -10.48 | -16.633 | -8.278 | -10.781 | -18.025 | -4.748 | -9.797 | -4.491 | -14.39 | -18.523 | -19.326 | -9.968 | -1.239 | -0.692 | -0.755 | -1.119 | 0.088 | -1.118 | -1.6 | -0.625 |
Total Other Income Expenses Net
| -0.159 | -0.319 | -0.066 | -0.008 | -0.005 | -0.965 | -0.4 | -0.255 | -14.618 | 0.013 | -1.902 | -0.883 | 0.008 | 0.01 | 0.06 | 0.07 | 0.142 | 0.188 | 0.032 | -0.001 | -0.073 | 0.023 | -0.28 | 0.038 | 0.035 | 0 | 0 | 0.2 | 0 |
Income Before Tax
| -3.35 | -3.961 | -3.491 | -2.319 | 0.004 | -6.554 | -7.442 | -6.263 | -14.371 | -7.627 | -11.05 | -7.671 | -8.746 | -8.357 | -6.758 | -7.065 | -6.538 | -4.652 | -3.681 | -3.012 | -2.7 | -3.187 | -2.5 | -1.781 | -1.825 | 0 | 0 | -1.4 | 0 |
Income Before Tax Ratio
| -1.707 | -2.11 | -1.884 | -0.591 | 0.001 | -3.433 | -4.195 | -3.421 | -11.149 | -10.462 | -20.091 | -9.355 | -10.771 | -18.004 | -4.706 | -9.701 | -4.395 | -13.831 | -18.363 | -19.331 | -10.246 | -1.231 | -0.78 | -0.739 | -1.098 | 0 | 0 | -1.4 | 0 |
Income Tax Expense
| -0.148 | 0.01 | 0.006 | -0.069 | 0.01 | 0.007 | 0.033 | 0.255 | 7.314 | -0.013 | 1.902 | 0.883 | 0.136 | -0.018 | 0.003 | 0.002 | 0.002 | 0.002 | 0.132 | -1.165 | -0.319 | 0.074 | 0.225 | 0.002 | 0.001 | 0 | 0 | -0.2 | -0.1 |
Net Income
| -3.35 | -3.961 | -3.497 | -2.319 | -0.006 | -6.561 | -7.475 | -6.518 | -21.685 | -7.614 | -12.952 | -8.554 | -8.882 | -8.339 | -6.76 | -7.067 | -6.54 | -4.655 | -3.813 | -1.847 | -2.381 | -3.261 | -2.725 | -1.782 | -1.825 | 0.3 | -1.9 | -1.2 | -0.4 |
Net Income Ratio
| -1.707 | -2.11 | -1.887 | -0.591 | -0.001 | -3.437 | -4.214 | -3.56 | -16.823 | -10.444 | -23.549 | -10.432 | -10.938 | -17.965 | -4.707 | -9.704 | -4.397 | -13.838 | -19.023 | -11.855 | -9.036 | -1.259 | -0.85 | -0.74 | -1.099 | 0.088 | -1.118 | -1.2 | -0.5 |
EPS
| -0.03 | -0.036 | -0.039 | -0.027 | -0 | -0.09 | -0.11 | -0.1 | -0.38 | -0.19 | -0.51 | -0.79 | -1.58 | -1.79 | -1.57 | -1.85 | -1.9 | -1.52 | -1.49 | -0.92 | -1.55 | -2.86 | -2.85 | -2.24 | -3.01 | 0.47 | -3.92 | -2.88 | -1.12 |
EPS Diluted
| -0.03 | -0.036 | -0.039 | -0.027 | -0 | -0.09 | -0.11 | -0.1 | -0.38 | -0.19 | -0.51 | -0.79 | -1.58 | -1.79 | -1.57 | -1.85 | -1.9 | -1.52 | -1.49 | -0.92 | -1.55 | -2.86 | -2.85 | -2.24 | -1.81 | 0.31 | -3.92 | -2.88 | -1.12 |
EBITDA
| -3.047 | -3.515 | -3.212 | -2.143 | 0.201 | -5.347 | -6.732 | -5.482 | 0.466 | -7.455 | -7.008 | -6.187 | -8.377 | -7.906 | -6.376 | -6.738 | -6.277 | -4.621 | -3.402 | -2.706 | -2.278 | -2.896 | -1.485 | -1.528 | -1.607 | 0.4 | -1.8 | -1.7 | -0.5 |
EBITDA Ratio
| -1.552 | -1.873 | -1.733 | -0.546 | 0.029 | -2.801 | -3.795 | -2.994 | 0.362 | -10.226 | -12.742 | -7.545 | -10.317 | -17.033 | -4.44 | -9.252 | -4.22 | -13.738 | -16.972 | -17.365 | -8.644 | -1.118 | -0.463 | -0.634 | -0.967 | 0.118 | -1.059 | -1.7 | -0.625 |